|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Washington Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing WashingtonLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
CompleGen, Inc.
| | | Phone: | (206) 447-9014 | Fax: | (206) 332-9590 | Year Established: | 2000 | Employees: | 7 | Main Contact: | John Swindle, Ph.D., President, CEO & Co-founder | | Other Contacts: | Pauline Gee, Ph.D., VP, Business Development
| |
| Company Description | CompleGen is a drug discovery company applying novel genetic technology that makes the discovery of biologically active compounds such as drugs or agricultural products more efficient. Their XenoGene™ system can drastically speed the discovery of compounds that specifically act on a given target and not on others. (A target is a molecule involved in a disease process, a normal process one wishes to affect or a function essential for maintenance of a pathogen.) The company's system is based on the replacement of genes of a microorganism that is well characterized and easily grown with functional gene(s) of the target organism or cell, while maintaining the ability to identify compounds that act specifically on the target gene product. The system allows CompleGen and its clients to exploit the massive amount of genomic information gained over the past decade and the thousands of chemical compounds generated by modern synthetic technologies to discover useful products (drugs and other biologically active chemicals). | |
|
|
|
|
|